Pathway to Cures
pathwaytocures.org Direct investor
Pathway to Cures is the National Bleeding Disorders Foundation's venture philanthropy fund, making equity investments in companies developing therapies and technologies for inheritable blood and bleeding disorders. It reinvests proceeds back into the fund to support its mission.
Pathway to Cures is an investor headquartered in New York, United States, founded in 2021. It invests directly in companies, in inheritable blood and bleeding disorders, therapeutics, diagnostics and medical devices.
“P2C takes a focused investment approach, investing only in companies that offer the potential to change the lives of those living with inheritable blood and bleeding disorders.”
— Pathway to Cures, own website
- Layer
- Direct investor
- Type
- Other
- Stage
- Not stated
- Headquarters
- New York, United States
- Sectors
- inheritable blood and bleeding disorders, therapeutics, diagnostics, medical devices, genetic medicines
- Founded
- 2021
Team, as Pathway to Cures publishes it
- Tim Brent, MBA P2C Managing Director & Officer
- Teri Willey Founding Managing Director Emeritus
- Michael Recht, MD, PhD, MBA Chair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor
- Leonard Valentino, MD P2C Entrepreneur in Residence
- Peter Harvey, MBA P2C Chief Financial Officer; and NBDF Chief Business Officer
- Beth Whitehouse NBDF Senior Vice President of Advancement
- Philip M. Gattone, M.Ed. P2C Board Member and NBDF President and CEO
- Scott Martin P2C Board Chair, Former Chair of the NBDF Board
- Amy L. Dunn, MD Chair, Medical and Scientific Advisory Council (MASAC) for NBDF
- Sharon Richardson, PhD A Director on the NBDF Board
- Gilbert C. White, II, MD P2C Board Vice Chair & Secretary
Names and roles exactly as listed on pathwaytocures.org. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Pathway to Cures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.pathwaytocures.org/name, hq_country, hq_city, thesis_quote, status
- https://www.pathwaytocures.org/investment-strategy/is_investor, layer, sectors
- https://www.pathwaytocures.org/about/type, description
- https://www.pathwaytocures.org/who-we-are/founded, people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 16070 · added 2026-10-21 · link last verified 2026-10-21 · confidence high
Similar investors
- Deerfield ManagementOther · Seed – Growth · New York, United States
- Research Corporation TechnologiesOther · Seed · Tucson, United States
- BioGenerator VenturesOther · Seed · St. Louis, United States
- Commodore CapitalOther · New York, United States
- 325 CapitalOther · Not applicable · New York, United States
- 3i FundOther · Growth · New York, United States